TFF3 is found to be upregulated in and responsible for, the development and progression of several cancers including gastric cancer [19], hepatocellular carcinoma [20–23], prostate cancer [24], cervical cancer [25], lung adenocarcinoma [26, 27] and breast cancer [28, 29]. Here, TFF3 is linked to breast carcinoma.